Curis, Inc. (CRIS)
1.35
-0.02
(-1.46%)
USD |
NASDAQ |
Sep 04, 16:00
1.36
+0.01
(+0.74%)
After-Hours: 20:00
Curis Total Liabilities (Quarterly) : 14.28M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 14.28M |
| March 31, 2026 | 16.98M |
| December 31, 2025 | 15.02M |
| September 30, 2025 | 42.33M |
| June 30, 2025 | 43.22M |
| March 31, 2025 | 45.93M |
| December 31, 2024 | 48.13M |
| September 30, 2024 | 51.21M |
| June 30, 2024 | 51.11M |
| March 31, 2024 | 52.56M |
| December 31, 2023 | 58.45M |
| September 30, 2023 | 60.38M |
| June 30, 2023 | 58.08M |
| March 31, 2023 | 57.95M |
| December 31, 2022 | 63.49M |
| September 30, 2022 | 67.11M |
| June 30, 2022 | 66.79M |
| March 31, 2022 | 64.76M |
| December 31, 2021 | 73.16M |
| September 30, 2021 | 69.18M |
| June 30, 2021 | 68.72M |
| March 31, 2021 | 68.68M |
| December 31, 2020 | 75.48M |
| September 30, 2020 | 74.32M |
| June 30, 2020 | 75.33M |
| Date | Value |
|---|---|
| March 31, 2020 | 66.98M |
| December 31, 2019 | 69.06M |
| September 30, 2019 | 68.26M |
| June 30, 2019 | 68.51M |
| March 31, 2019 | 69.18M |
| December 31, 2018 | 41.86M |
| September 30, 2018 | 43.48M |
| June 30, 2018 | 46.08M |
| March 31, 2018 | 46.91M |
| December 31, 2017 | 49.80M |
| September 30, 2017 | 51.92M |
| June 30, 2017 | 54.57M |
| March 31, 2017 | 52.29M |
| December 31, 2016 | 28.49M |
| September 30, 2016 | 28.32M |
| June 30, 2016 | 27.92M |
| March 31, 2016 | 29.38M |
| December 31, 2015 | 30.45M |
| September 30, 2015 | 30.12M |
| June 30, 2015 | 31.00M |
| March 31, 2015 | 31.69M |
| December 31, 2014 | 32.83M |
| September 30, 2014 | 33.56M |
| June 30, 2014 | 34.49M |
| March 31, 2014 | 34.83M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 1.012B |
| Imunon, Inc. | 10.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 18.97M |
| Shareholders Equity (Quarterly) | 4.695M |
| Debt to Equity Ratio | 0.2224 |
| Current Ratio | 0.4917 |
| Net Debt Paydown Yield | 32.73% |